Research Alliance Corp IIIRACC

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$11.06
Market cap
—
P/E
—
Revenue (FY)
—
Net income
—
Dividend yield
—
1-year total return
—
Net margin
—
Revenue growth
—
Debt / equity
—

What Research Alliance Corp III does.

No business description on file yet.

More on RACC.

Figures from Research Alliance Corp III's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.